AIC
ALNY icon

Archer Investment Corporation’s Alnylam Pharmaceuticals ALNY Stock Holding History

Archer Investment Corporation’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.01K Hold
10
– – ﹤0.01% 1021
2026
Q1 		$3.31K Hold
10
– – ﹤0.01% 992
2025
Q4 		$3.98K Hold
10
– – ﹤0.01% 902
2025
Q3 		$4.56K Hold
10
– – ﹤0.01% 885
2025
Q2 		$3.26K Buy
+10
New +$2.77K ﹤0.01% 905
2024
Q1 		– Sell
-200
Closed -$38.3K – 1046
2023
Q4 		$38.3K Hold
200
– – 0.01% 440
2023
Q3 		$35.4K Hold
200
– – 0.01% 427
2023
Q2 		$38K Hold
200
– – 0.01% 414
2023
Q1 		$40.1K Buy
+200
New +$42K 0.01% 411

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Archer Investment Corporation's ALNY Position: Q2 2026 in Review

Archer Investment Corporation held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 10 shares worth $3.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1021.

Archer Investment Corporation first reported a position in ALNY in Q1 2023 and has held it in 9 quarters since. The position peaked at $40.1K in Q1 2023. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Archer Investment Corporation held 10 shares of Alnylam Pharmaceuticals worth $3.01K as of Q2 2026.
  • Archer Investment Corporation left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #1021 holding.
  • Archer Investment Corporation first reported a position in Alnylam Pharmaceuticals in Q1 2023 and has held it in 9 quarters since.
  • Archer Investment Corporation's Alnylam Pharmaceuticals position peaked at $40.1K in Q1 2023.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.